Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia (Q38876224)

7 September 2017

1 reference

title

Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia (English)

1 reference

7 September 2017

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342132%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342132%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

J de Bie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342132%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

24 June 2016

1 reference

7 September 2017

published in

Neurotoxicity Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342132%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342132%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342132%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

285-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342132%20AND%20SRC:MED&resulttype=core&format=json

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Estrogen-mediated neuroprotection in the cortex may require NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

In vitro trials to counteract the inhibitory effect of beta-oestradiol and ethynyloestradiol on the B6-dependent kynurenine aminotransferase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Age of onset of schizophrenia: perspectives from structural neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Quinolinic acid, the inescapable neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Estradiol acutely attenuates glutamate-induced calcium overload in primarily cultured rat hippocampal neurons through a membrane receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

The role of serotonin in schizophrenia. New findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Imbalanced kynurenine pathway in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Estrogen - a potential treatment for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Estrogen attenuates lipopolysaccharide-induced nitric oxide production in macrophages partially via the nongenomic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Sex Differences Distinguish Intracortical Glutamate Receptor-Mediated Regulation of Extracellular Dopamine Levels in the Prefrontal Cortex of Adult Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Schizophrenia and the alpha7 nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Microduplications of 16p11.2 are associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Para/autocrine regulation of estrogen receptors in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

IDO2 in Immunomodulation and Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Can estradiol modulate schizophrenic symptomatology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Aspects of tryptophan metabolism in health and disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Longitudinal study of tryptophan degradation during and after pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: An association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-016-9641-5

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

21 January 2018

1 reference

12 December 2020

Vitamin B6 requirements of women using oral contraceptives

1 reference

12 December 2020

Gender aspects in schizophrenia: bridging the border between social and biological psychiatry.

1 reference

12 December 2020

The influence of sex, age, synthetic oestrogens, progestogens and oral contraceptives on the excretion of urinary tryptophan metabolites

1 reference

12 December 2020

Schizophrenia: age at onset, gender and familial risk

1 reference

12 December 2020

Effects of sex hormones on three glucocorticoid-inducible enzymes concerned with amino acid metabolism in rat liver

1 reference

12 December 2020

Two mechanisms which increase in vivo the liver tryptophan peroxidase activity: specific enzyme adaptation and stimulation of the pituitary adrenal system

1 reference

12 December 2020

The neuropathology of schizophrenia

1 reference

12 December 2020

The physiological action of picolinic Acid in the human brain

1 reference

12 December 2020

Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome

1 reference

12 December 2020

Kynurenine pathway metabolites in humans: disease and healthy States

1 reference

12 December 2020

Kynurenic acid and schizophrenia

1 reference

12 December 2020

Effect of natural oestrogens on tryptophan metabolism: evidence for interference of oestrogens with kynureninase

1 reference

12 December 2020

Managing resistant schizophrenia

1 reference

12 December 2020